Last price paid | 3.62 | |
Change | +0.84% [ +0.03 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 09.04.2021 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | n.a. |
Year to date (YTD) | +39.77% |
1 month | +5.85% |
3 months | +16.40% |
1 year | +69.16% |
3 years | n.a. |
Issue price | 1.64 |
Underlying price on issue | 406.90 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH0596290111 |
Symbol | IZUADZ |
Security | 59629011 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Zurich Insur Gr N, CH0011075394 |
Underlying ISIN | CH0011075394 |
Funding level | 300.974700 |
Stop-loss level | 315.607700 |
Distance to stop-loss level | n.a. |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 07.04.2021 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Moneyness | out-of-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | n.a. |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 100.22 |
Alcon AG | 81.42 |
ROCHE GS | 253.50 |
UBS | 27.89 |
SWISSCOM N | 528.00 |
Name | Price |
---|---|
KUEHNE & NAGEL | 256.40 |
Swiss Life Hldg | 673.60 |
Givaudan | 4'343.00 |
LOGITECH INT. | 81.48 |
Lonza Group | 519.00 |